No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract CASTOR trial follow-up: Health-related quality of life was maintained in patients treated with daratumumab, bortezomib, and dexamethasone over time for relapsed or refractory multiple myeloma

byKathleen Lau

March 4, 2021

in StudyGraphics

#VisualAbstract: Higher metastatic lymph node burden is associated with worse overall survival in Merkel cell carcinoma

RelatedReports

Quick Take: Hospital volume and outcomes for acute pulmonary embolism

Cardiology

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism

April 30, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation

StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025

Galangin may sensitize apoptosis-resistant renal carcinoma cells [PreClinical]

Cabozantinib improves progression-free survival in patients with metastatic papillary renal cell carcinoma

#VisualAbstract: Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%

#VisualAbstract: Relugolix combination therapy led to reduction in uterine fibroid symptoms

#VisualAbstract OAsIS: Ibrutinib, obinutuzumab, and venetoclax was well-tolerated and showed high response rates in both untreated and relapsed mantle cell lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports